Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07603518 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Pharmacokinetics of a Hemp-Based Topical Product

StatusRecruiting
PhasePhase 1
Started2026-05-26
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 12 months later across 2 updates Aug 2026 → Sep 1, 2027
See other at-risk trials from Johns Hopkins University

Amendment history

2026-09-02
critical
Study Status v2
Primary completion pushed: 2026-09 → 2027-09-01
Completion pushed: 2026-09 → 2027-09-01
2026-08-10
notable
Study Status, Contacts/Locations v1
Recruitment opened
Primary completion pushed: 2026-08 → 2026-09
Start dateestimated 2026-06→confirmed 2026-05-26
Study sitesdetails revised at 1 of 1 site
2026-05-18
minor
Original filing
This study will evaluate the pharmacokinetic effects of acute and chronic dosing of a hemp-based cannabidiol (CBD) topical lotion with low levels of delta-9-tetrahydrocannabinol (THC) in a sanitized and controlled environment.
Trial Details
NCT Number NCT07603518
Lead Sponsor Johns Hopkins University
Collaborators: RTI International, Substance Abuse And Mental Health Administration
Conditions Cannabis
Enrollment 20 participants
Start Date 2026-05-26
Primary Completion 2027-09-01 (estimated)
Study Completion 2027-09-01 (estimated)
Updated on ClinicalTrials.gov 2026-09-03